The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities below and streamline your search by using keyword or type of funding.
Highlighted Topics
Published topics related to the NCI Division of Cancer Prevention Research Areas
| Title | Posted Date | Expiration Date |
|---|---|---|
| Research on Rare Cancers Across the Cancer Control Continuum | February 20, 2026 | February 20, 2028 |
| Advancing Nanotechnology Research to Improve Diagnosis and Treatment Options | March 10, 2026 | March 10, 2028 |
| Advancing Toward a Cure for Acquired Neuropathy | April 6, 2026 | April 6, 2028 |
| Advancing Mechanism-driven Translational Research of Beneficial and Detrimental Effect of Psilocybin on Cancer and Other Health Conditions | April 10, 2026 | April 10, 2028 |
| GLP-1s: Implications for Nutritional Status and Metabolic Health | April 24, 2026 | April 24, 2028 |
Note: Highlighted topics have replaced Notice of Special Interest Announcements.
Please also check the “Other Notices” tab on the NIH Guide for Grants and Contracts to see updates to NIH policies that ensure alignment with the Administration’s priorities.
Notice of Funding Opportunities
| Title | Announcement Number | Activity Code | Clinical Trials Status | Expiration Date Sort descending | Program Official |
|---|---|---|---|---|---|
| NIH Research Project Grant | PA-25-301 (Parent R01 Clinical Trial Not Allowed) | R01 | Clinical Trial Not Allowed | 01/07/2028 | Asad Umar, D.V.M., Ph.D. |
| NIH Exploratory/Developmental Research Project Grant | PA-25-304 (Parent R21 Clinical Trial Not Allowed) | R21 | Clinical Trial Not Allowed | 01/08/2028 | Marjorie Perloff, M.D. |